#FDAUpdate
This bright red dye, linked to safety concerns, is being phased out to protect public health. Manufacturers have until 2027 for foods and 2028 for medications to remove it.
What are your thoughts on this decision? Let’s discuss!
#FoodSafety #FDAUpdate #HealthierChoices #PublicHealth
January 21, 2025 at 2:08 PM
🚨 FDA 2024 Guidance: CAR T Cell Therapy
This new guidance is a must-read for sponsors & developers.
✅ Cell design
✅ CMC expectations
✅ Clinical & nonclinical updates

📖 Read now → compliancearchitects.com/ca...

#CARTCell #CellTherapy #FDAupdate #GeneTherapy #BiotechCompliance
June 27, 2025 at 12:15 PM
🚨 The FDA warns of rare but severe itching (pruritus) after stopping daily use of Zyrtec® (Cetirizine) or Xyzal® (levocetirizine).

Symptoms can appear days after stopping, even with no rash. It’s linked to long-term use and this is an extremely rare side effect.

#FDAUpdate #AllergyAwareness
July 1, 2025 at 2:03 PM
A new chapter in hormone health! 🌟 The FDA's decision on estradiol is changing the landscape of hormone replacement therapy. Learn what this means for you with insights from Dr. Betty Murray. #FDAUpdate #HormoneHealth #MenopauseMastery
August 21, 2025 at 4:31 PM
Novo Nordisk’s Wegovy 0.25 mg dose is back on the market, easing supply issues. This lowest dose option joins the full lineup of Wegovy and Ozempic doses now available.

jcst2d.com/index.php?vi...

#Wegovy #FDAUpdate #WeightLoss #NovoNordisk
October 30, 2024 at 8:46 PM
The FDA has approved a PD-1–targeted monoclonal antibody for use in advanced squamous cell carcinoma of the anal canal.
#GastroOncology #FDAUpdate
FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC
The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.
conexiant.com
May 16, 2025 at 6:45 PM
FDA drops estrogen warning, potentially transforming menopause care for millions. Doctors call it a “positive step” after decades of restrictions. Comment “article” to see how this affects you. 🧵 #MenopauseCare #WomensHealth #EstrogenTherapy #FDAUpdate #HormoneHealth #HealthNews
November 15, 2025 at 6:02 PM
Why did 6 FDA fast-track vouchers just reshape biotech timelines? See how this impacts reviews, funding, and drug launches in 2024. Full analysis on onlytrustedinfo.com. #FDAupdate #PharmaTrends
FDA’s Fast-Track Voucher Surge: How 6 New Awards Instantly Impact the Drug Approval Race
The FDA just issued six more fast-track review vouchers, instantly accelerating drug approvals for 15 companies and sending shockwaves through pharmaceutical innovation, investment decision-making, and patient access to game-changing therapies.The Fast-Track Voucher: A Critical Catalyst for Innovati
www.onlytrustedinfo.com
November 14, 2025 at 2:44 PM
The FDA has lifted its two-decade-old black box warning from hormone-based menopause drugs, citing updated research and modern clinical guidance.

#FDAUpdate #HealthNews #HormoneTherapy #Menopause #MedicalChange
FDA Removes Long-Standing Safety Warning from Menopause Hormone Therapy Drugs
The U.S. Food and Drug Administration (FDA) has removed its long-standing “black box” warning from more than 20 hormone-based menopause
journosnews.com
November 11, 2025 at 12:40 AM
Big news for adults with growth hormone deficiency! SKYTROFA® may soon expand to help more people live healthier lives. Stay tuned for updates! #MedicalBreakthrough #HealthNews #FDAUpdate #GrowthHormoneDeficiency#HealthNews #GrowthHormone #MedicalInnovation #FDAApproval #FYP #MedicalBreakthrough
December 14, 2024 at 2:00 AM
𝗙𝗗𝗔 𝗨𝗣𝗗𝗔𝗧𝗘: Testosterone 𝗱𝗼𝗲𝘀 𝗡𝗢𝗧 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗵𝗲𝗮𝗿𝘁 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗿𝗶𝘀𝗸!
​
The warning is 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹𝗹𝘆 𝗥𝗘𝗠𝗢𝗩𝗘𝗗 for most products.
​
This is big news for men & women! ✅
​
Need expert guidance on hormone health? Let's talk!

#FDAUpdate #PinnacleIntegrativeOrthopedics
March 7, 2025 at 12:52 AM